Developing and Enhancing Prescription Drug Monitoring Programs (PDMPs)

The summary for the Developing and Enhancing Prescription Drug Monitoring Programs (PDMPs) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Bureau of Justice Assistance, which is the U.S. government agency offering this grant.

Developing and Enhancing Prescription Drug Monitoring Programs (PDMPs): The primary purpose of the Prescription Drug Monitoring Program (PDMP) is to enhance the capacity of regulatory and law enforcement agencies to collect and analyze controlled substance prescription data through a centralized database administered by an authorized state agency. The Prescription Drug Monitoring Program assists states as they plan, implement, or enhance a PDMP. PDMPs build a data collection and analysis system at the state level; enhance existing programs abilities to analyze and use collected data; facilitate national evaluation efforts; encourage the exchange of information and collected prescription data among states; assess the efficiency and effectiveness of programs; and enhance collaborations with law enforcement, prosecutors, treatment professionals, the medical community, and pharmacies.